Literature DB >> 17311515

Lipid transfer protein activities in subjects with impaired glucose tolerance.

Ulrich Julius1, Matti Jauhiainen, Christian Ehnholm, Jens Pietzsch.   

Abstract

BACKGROUND: Impaired glucose tolerance (IGT) is associated with an increased risk of atherosclerosis that may be due in part to dyslipidemia. The purpose of this study was to assess the regulatory role of lipid transfer proteins in the development of this dyslipidemia.
METHODS: Activities of cholesterol ester transfer protein (CETP) and phospholipid transfer protein (PLTP), as well as lipid and protein components of the major lipoprotein fractions, were evaluated in probands with IGT and were compared with those in subjects with normal glucose tolerance. The effect of a fat-rich meal on these variables was also investigated.
RESULTS: IGT probands had a higher triglyceride content in subfractions of low- (LDL) and high-density lipoprotein (HDL). IGT patients had higher fasting CETP activity. The latter was positively correlated with HDL2 triglycerides and negatively with HDL3 total cholesterol. PLTP activity and mass were not higher in IGT patients. However, PLTP activity correlated with components of VLDL and LDL and was influenced by the type of obesity. Neither CETP and PLTP activities nor PLTP mass were altered by a fat-rich meal. PLTP and CETP activities correlated in both fasting and postprandial conditions.
CONCLUSIONS: Increased fasting CETP activity may contribute to increased risk of atherosclerosis in subjects with IGT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311515     DOI: 10.1515/CCLM.2007.032

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  2 in total

1.  Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A₂ in subjects with prediabetes.

Authors:  Theodosios D Filippatos; Evangelos C Rizos; Vasilios Tsimihodimos; Irene F Gazi; Alexandros D Tselepis; Moses S Elisaf
Journal:  Lipids       Date:  2013-04-02       Impact factor: 1.880

2.  Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes.

Authors:  Axel Schlitt; Bernhard Schwaab; Kirsten Fingscheidt; Karl J Lackner; Gunnar H Heine; Alexander Vogt; Michael Buerke; Lars Maegdefessel; Uwe Raaz; Karl Werdan; Xian-Cheng Jiang
Journal:  Lipids       Date:  2010-01-27       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.